Researchers have found that Australia and New Zealand have the highest incidence rate of breast cancer in the world.
The Global Patterns and Trends in Breast Cancer Incidence and Mortality report uses 2022 data from 185 countries to project the global breast cancer impact by 2050.
The University of Sydney, University of Queensland and Alberta Health Services in Canada teamed up to deliver the report. A stark reminder that breast cancer is still a major health issue.
“Breast cancer remains the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related death.”
Fortunately, data shows that while Australia's incidence rate is high, the mortality rate is low and getting lower. The study found that Australia and NZ's breast cancer mortality rate has been dropping, by 2.1 per cent per year.

Picture: NCA Newswire
Breast Cancer Network Australia (BCNA) director of policy, advocacy, and support services Vicki Durston has renewed calls for ongoing national investment into what the organisation calls the three pillars for reducing breast cancer mortality – prevention, social support, and education.
“These are harsh facts, a warning that cannot be ignored. Breast cancer continues to have a profound impact in Australia and around the world, now isn’t the time for complacency,” Ms Durston said.
“We need sustained investment, coordinated national action, and a commitment to prevention, early detection, treatment access, and strong data systems if we are to see further progress.”
Professor Nehmat Houssami, Professor of Public Health and National Breast Cancer Foundation chair at the University of Sydney, said it is important to recognise the significant global disparities in breast cancer mortality.

“The study shows the worldwide substantial burden of breast cancer – most or second most common female cancer and the leading cause of cancer deaths in females in the majority of nations,” Professor Houssami said.
“However this burden is not spread equally across countries and regions, there are large variations in incidence rates, and more concerning are the disparities in breast cancer mortality.
"Countries that are less affluent and have less developed health systems (measured using the HDI in the study) have much worse breast cancer outcomes (higher mortality) than the more developed/affluent countries. So a woman who develops breast cancer in a low-middle income country has a higher likelihood of dying from her cancer than her counterpart in a high-income country."
On the fact that Australia and NZ have the highest incidence rates of breast cancer globally, she said it was partly associated with our ageing populations and also cited risk factors including levels of alcohol consumption, low physical activity, and post-menopausal obesity.
"We need to improve support for women to reduce these potentially modifiable risk factors,” she said.
Related: World first as NSW identifies number of people with metastatic breast cancer | Nurses could perform women’s health checks to prevent ED visits, says APNA | Albanese’s $573m for women’s health
Productivity burden
In a bid to better understand the impact of breast cancer on working-age Australian women, a team of researchers from Monash University looked at just how many work hours (and therefore wages) they lose to breast cancer.
Led by the Centre for Medicine Use and Safety (CMUS) within the Monash Institute of Pharmaceutical Sciences in collaboration with Monash’s School of Public Health and Preventative Medicine (SPHPM) the paper reveals the profound impact of a diagnosis, across a 10 year period.
“Of the estimated 10,732 working-age Australian women diagnosed with breast cancer in 2022, they will collectively lose a projected AU$1.4 billion in wage earnings over the 10-year period post diagnosis.”
One of the study's first authors Dr Melanie Lloyd (CMUS) said breast cancer-related productivity and economic losses are exceeding healthcare costs.
“By quantifying the economic burden associated with breast cancer in Australia in terms of diminished productivity, this study substantiates the need for funding initiatives that aid integration back into the workforce,” Dr Lloyd said.
“Helping to support a woman's journey back into the workforce is not only beneficial to the individual but could also help to reduce the economic burden of cancer in Australia.”
